ビブラスラップのミュージネスマン！

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月09日 23:22

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月10日 05:34

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月10日 11:03

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月10日 15:23

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月10日 21:51

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月11日 03:19

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月12日 00:11

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月12日 05:07

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月12日 15:10

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月12日 20:23

http://aldacton.health-good.org/aldactone.php >aldactone acne
http://statinsmef.health-good.org/pravacholpra.php >adverse effects pravastatin
http://buyonli.health-good.org/cozaarhyzaar.php >losartan cozaar
http://seroquelb.health-good.org/cephalexinser.php
>
http://adderallse.health-good.org/adderall.php >effexor vs cymbalta
http://dietfreelexd.health-good.org/contactos.php >lactose shop
http://statinsmef.health-good.org/lovastat.php >or lovastatin
http://sideeffectsno.health-good.org/tamifluin.php >tamiflu infant
http://dietfreelexd.health-good.org/diosdepacto.php >pactos free dios
http://dietfreelexd.health-good.org/concontactosp.php >actos norvasc

petro
2007年05月13日 03:00

http://aldacton.health-good.org/aldactone.php >aldactone acne
http://statinsmef.health-good.org/pravacholpra.php >adverse effects pravastatin
http://buyonli.health-good.org/cozaarhyzaar.php >losartan cozaar
http://seroquelb.health-good.org/cephalexinser.php
>
http://adderallse.health-good.org/adderall.php >effexor vs cymbalta
http://dietfreelexd.health-good.org/contactos.php >lactose shop
http://statinsmef.health-good.org/lovastat.php >or lovastatin
http://sideeffectsno.health-good.org/tamifluin.php >tamiflu infant
http://dietfreelexd.health-good.org/diosdepacto.php >pactos free dios
http://dietfreelexd.health-good.org/concontactosp.php >actos norvasc

petro
2007年05月13日 03:00

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月13日 06:43

http://jislamic.igreatart.com/fluidhistorym.php >kid fluid
http://compute.igreatart.com/houseimagesat.php >internet image
http://casheasy.igreatart.com/linkloanonline.php >online advance payday
http://dbookgu.igreatart.com/advance.php >care advanced examined
http://accountmarketv.igreatart.com/index.php >online completing survey
http://botcompa.igreatart.com/robotcom.php >asimov robot combat
http://baltimorewan.igreatart.com/orthodon.php >wang orthodontics baltimore
http://ufreeonl.igreatart.com/affiliatecommi.php >affiliate directory
http://botcompa.igreatart.com/airlinedisco.php >discount biped robot
http://zfocusonph.igreatart.com/travelnur.php >california travel frontier

visimu
2007年05月13日 06:54

http://jislamic.igreatart.com/fluidhistorym.php >kid fluid
http://compute.igreatart.com/houseimagesat.php >internet image
http://casheasy.igreatart.com/linkloanonline.php >online advance payday
http://dbookgu.igreatart.com/advance.php >care advanced examined
http://accountmarketv.igreatart.com/index.php >online completing survey
http://botcompa.igreatart.com/robotcom.php >asimov robot combat
http://baltimorewan.igreatart.com/orthodon.php >wang orthodontics baltimore
http://ufreeonl.igreatart.com/affiliatecommi.php >affiliate directory
http://botcompa.igreatart.com/airlinedisco.php >discount biped robot
http://zfocusonph.igreatart.com/travelnur.php >california travel frontier

visimu
2007年05月13日 06:55

http://jislamic.igreatart.com/fluidhistorym.php >kid fluid
http://compute.igreatart.com/houseimagesat.php >internet image
http://casheasy.igreatart.com/linkloanonline.php >online advance payday
http://dbookgu.igreatart.com/advance.php >care advanced examined
http://accountmarketv.igreatart.com/index.php >online completing survey
http://botcompa.igreatart.com/robotcom.php >asimov robot combat
http://baltimorewan.igreatart.com/orthodon.php >wang orthodontics baltimore
http://ufreeonl.igreatart.com/affiliatecommi.php >affiliate directory
http://botcompa.igreatart.com/airlinedisco.php >discount biped robot
http://zfocusonph.igreatart.com/travelnur.php >california travel frontier

visimu
2007年05月13日 06:55

http://notebookomau.igreatart.com/disadvanta.php >advantages disadvantage
http://yinjewel.igreatart.com/index.php >factory r kelly
http://rolexbandvbag.igreatart.com/rolexrepl.php >replica under by
http://hhomebus.igreatart.com/entrepreneur.php >domain business home
http://adultfinderfr.igreatart.com/cupidshot.php >hot cupid cupids
http://musicindustryk.igreatart.com/ppcmarketing.php >internet article
http://freeprintabl.igreatart.com/resumecv.php >resume plumber
http://cordlessqdire.igreatart.com/ipodmic.php >microphone pc ipod
http://erskinevn.igreatart.com/5academybo.php >fantasia sports borang
http://bonethugncros.igreatart.com/akonbonef.php >akon lyric tried

joni
2007年05月13日 09:16

http://janitorialmi.igreatart.com/index.php >janitorial west
http://findabyname.igreatart.com/index.php >doctor virginia
http://bodypiercing.igreatart.com/bodypiercin.php >body lip
http://cneylamp.igreatart.com/xemphimboonlin.php >himalayan salt
http://andnigh.igreatart.com/naturalh.php >headache natural relief
http://enginegooglem.igreatart.com/gatewayapar.php >wrought apartment
http://makeonlyspace.igreatart.com/codefriends.php >markie friendster friend
http://sxgainesvill.igreatart.com/botanicalins.php >cockroach insecticides botanical
http://swedishc.igreatart.com/adelaid.php >adelaide st royal
http://ingprocessp.igreatart.com/embalmingproc.php >embalming process

plium
2007年05月13日 10:53

http://janitorialmi.igreatart.com/index.php >janitorial west
http://findabyname.igreatart.com/index.php >doctor virginia
http://bodypiercing.igreatart.com/bodypiercin.php >body lip
http://cneylamp.igreatart.com/xemphimboonlin.php >himalayan salt
http://andnigh.igreatart.com/naturalh.php >headache natural relief
http://enginegooglem.igreatart.com/gatewayapar.php >wrought apartment
http://makeonlyspace.igreatart.com/codefriends.php >markie friendster friend
http://sxgainesvill.igreatart.com/botanicalins.php >cockroach insecticides botanical
http://swedishc.igreatart.com/adelaid.php >adelaide st royal
http://ingprocessp.igreatart.com/embalmingproc.php >embalming process

plium
2007年05月13日 10:54

http://janitorialmi.igreatart.com/index.php >janitorial west
http://findabyname.igreatart.com/index.php >doctor virginia
http://bodypiercing.igreatart.com/bodypiercin.php >body lip
http://cneylamp.igreatart.com/xemphimboonlin.php >himalayan salt
http://andnigh.igreatart.com/naturalh.php >headache natural relief
http://enginegooglem.igreatart.com/gatewayapar.php >wrought apartment
http://makeonlyspace.igreatart.com/codefriends.php >markie friendster friend
http://sxgainesvill.igreatart.com/botanicalins.php >cockroach insecticides botanical
http://swedishc.igreatart.com/adelaid.php >adelaide st royal
http://ingprocessp.igreatart.com/embalmingproc.php >embalming process

plium
2007年05月13日 10:54

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月13日 11:50

Thank you for a very informative site. http://www.blog.fory.pl/jackets/

Racing jackets
2007年05月13日 15:11

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).

RobSeidman
2007年05月13日 22:59

http://wallpapertodow.sashax3m.com/converterfr.php >monty converter free
http://buildingsq.sashax3m.com/index.php >tuscan ringtone mobile
http://forwardi.sashax3m.com/ringtonepa.php >free ringtones beautiful
http://rockmelonbo.sashax3m.com/index.php >free r225m rington4
http://gmstracfones.sashax3m.com/mpringtonesway.php >sway dect mp
http://freepolyphon.sashax3m.com/thegame50cent.php >game formats cent
http://freetamilsfors.sashax3m.com/puertori.php >ringtone x fantasy
http://freeatt.sashax3m.com/hillsnv.php >ringtone v motorola
http://freesforvir.sashax3m.com/index.php >ringtones yahama
http://forwardi.sashax3m.com/milanring.php >for milan downloadable